2009-01-21
CT coronary angiography: validation and clinical implementation
Publication
Publication
CT coronair angiografie: validatie en klinische implementatie
Coronary heart disease is the most frequent cause of death in the Western society.1 Coronary arteriography, a technique to visualize morphologic characteristics of the coronary arteries, has provided an objective basic standard of diagnosis and fundamentally changed our approach to the patient with suspected coronary artery disease.
| Additional Metadata | |
|---|---|
| , | |
| Netherlands Heart Foundation, Abbott Vascular, Boston Scientific, Bristol-Myers Squibb, Medtronic, Merck Sharpe & Dohme BV, Novartis Pharma B.V., Pfizer bv, Radi Medical Systems BV, Servier Nederland B.V., Siemens Nederland N.V., Volcano | |
| P.W.J.C. Serruys (Patrick) , P.J. de Feyter (Pim) | |
| Erasmus University Rotterdam | |
| hdl.handle.net/1765/14640 | |
| Organisation | Erasmus MC: University Medical Center Rotterdam |
|
van Mieghem, C. (2009, January 21). CT coronary angiography: validation and clinical implementation. Retrieved from http://hdl.handle.net/1765/14640 |
|
| Additional Files | |
|---|---|
| 2853_Mieghem, Carlos Amedee Georgette van.jpg Cover Image , 15kb | |
| stellingen proefschrift_Van_Mieghem.pdf , 14kb | |
